Evidence map›Paper›PMID 35262734›Full record

ArticleInvestigative ophthalmology & visual science2022

Evaluation of Local Rod and Cone Function in Stargardt Disease.

Krunoslav Stingl, Carel Hoyng, Melanie Kempf, Susanne Kohl, Ronja Jung, Giulia Righetti, Laura Kühlewein, Lisa Pohl, Friederike Kortüm, Carina Kelbsch and 4 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. ABCA4-associated disease in childhood and adolescence- a phenotype study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Central retina plays a decisive role in the suppression of pupillary escape.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Krunoslav StinglUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Carel HoyngDepartment of Ophthalmology, Radboud University Medical Centre, 6500HB Nijmegen, the Netherlands.
Melanie KempfUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Susanne KohlInstitute for Ophthalmic Research, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Ronja JungUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Giulia RighettiUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Laura KühleweinUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Lisa PohlUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Friederike KortümUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Carina KelbschUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Barbara WilhelmPupil research group, University of Tuebingen, Tuebingen, Germany.
Tobias PetersInstitute for Ophthalmic Research, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Katarina StinglUniversity Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
SORAPRAZAN consortium
STZ eyetrial · DERadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: In this study, chromatic pupil campimetry (CPC) was used to map local functional degenerative changes of cones and rods in Stargardt disease (STGD1). Methods: 19 patients (age 36 ± 8 years; 12 males) with genetically confirmed ABCA4 mutations and a clinical diagnosis of STGD1 and 12 age-matched controls (age 37 ± 11 years; 2 males) underwent scotopic (rod-favoring) and photopic (cone-favoring) CPC. CPC evaluates the local retinal function in the central 30° visual field via analysis of the pupil constriction to local stimuli in a gaze-corrected manner. Results: Scotopic CPC revealed that the rod function of patients with STGD1 inside the 30° visual field was not impaired when compared with age-matched controls. However, a statistically significant faster pupil response onset time (∼ 40 ms) was observed in the measured area. Photopic CPC showed a significant reduction of the central cone function up to 6°, with a minor, non-significant reduction beyond this eccentricity. The time dynamic of the pupillary response in photopic CPC did not reveal differences between STGD1 and controls. Conclusions: The functional analysis of the macular region in STGD1 disease indicates reduced central cone function, corresponding to photoreceptor degeneration. In contrast, the rod function in the central area was not affected. Nevertheless, some alteration of the time dynamics in the rod system was observed indicating a complex effect of cone degeneration on the functional performance of the rod system. Our results should be considered when interpreting safety and efficacy in interventional trials of STGD1.

Indexed as

Retinal Cone Photoreceptor CellsStargardt DiseaseVisual Field TestsAdultATP-Binding Cassette TransportersElectroretinographyFemaleHumansMaleMiddle AgedRetinaVisual FieldsABCA4 protein, humanATP-Binding Cassette Transporters

Identifiers

PMID35262734
PMCPMC8934563
OpenAlexW4220746878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.